Financing ·
Bone Biologics Corporation priced a private offering of pre-funded warrants and Series F and G warrants to purchase…
BBLGBone Biologics Corp
Bone Biologics Corporation priced a private offering of pre-funded warrants and Series F and G warrants to purchase 2,112,677 shares of common stock at a combined price of $1.419 per warrant. The offering generated approximately $2.7 million in net proceeds, with potential additional gross proceeds of $6 million if all warrants are exercised. Bone Biologics Corporation is a biotechnology company focused on developing bone biologics products.